| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1097-0215(20010220)96:1<41::AID-IJC5>3.0.CO;2-F |
| P698 | PubMed publication ID | 11241329 |
| P2093 | author name string | D M Aebersold | |
| R H Greiner | |||
| A Kollar | |||
| J Laissue | |||
| K T Beer | |||
| V Djonov | |||
| P2860 | cites work | Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product | Q24310794 |
| Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria | Q24311858 | ||
| Disruption of epithelial cell-matrix interactions induces apoptosis | Q24673611 | ||
| Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex | Q28263687 | ||
| A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family | Q28285975 | ||
| Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis | Q28295920 | ||
| Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity | Q28306175 | ||
| The role of the stress-activated protein kinase (SAPK/JNK) signaling pathway in radiation-induced apoptosis | Q28611462 | ||
| The Bcl-2 protein family: arbiters of cell survival | Q29618158 | ||
| Signal transduction and cellular radiation responses | Q33835066 | ||
| Scatter factor induces blood vessel formation in vivo | Q36141804 | ||
| Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization | Q36642174 | ||
| Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor | Q36705281 | ||
| Calcium-dependent stimulation of mitogen-activated protein kinase activity in A431 cells by low doses of ionizing radiation. | Q41037685 | ||
| EGF receptor phosphorylation is affected by ionizing radiation | Q41079746 | ||
| Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. | Q41218044 | ||
| Radiation-induced autophosphorylation of epidermal growth factor receptor in human malignant mammary and squamous epithelial cells. | Q41256548 | ||
| The proto-oncogene Bcl-2 and its role in regulating apoptosis | Q41492030 | ||
| Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2. | Q41559408 | ||
| A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor | Q41879451 | ||
| Scatter factor is a fibroblast-derived modulator of epithelial cell mobility | Q42807925 | ||
| Tyrosine kinase receptor indistinguishable from the c-met protein | Q42814654 | ||
| Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. | Q42991716 | ||
| bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes | Q44192187 | ||
| Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells.Miko | Q44863595 | ||
| Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells | Q45889537 | ||
| The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation | Q46204815 | ||
| Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents | Q47801960 | ||
| Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death | Q47999769 | ||
| Bcl-xL and Bcl-2 expression in squamous cell carcinoma of the head and neck. | Q52533610 | ||
| bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer. | Q52922659 | ||
| Cumulative prognostic value of p53 mutations and bcl-2 protein expression in head-and-neck cancer treated by radiotherapy. | Q54072035 | ||
| Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy | Q62690767 | ||
| Bcl-2 overexpression and smoking history in head and neck cancer | Q71943991 | ||
| bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells | Q73074287 | ||
| Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage | Q73316771 | ||
| Association of Grb2 with Sos and Ras with Raf-1 upon gamma irradiation of breast cancer cells | Q73536153 | ||
| Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas | Q73586595 | ||
| Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck | Q73779194 | ||
| The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase | Q73816403 | ||
| Influence of p53 and bcl-2 on proliferative activity and treatment outcome in head and neck cancer patients | Q73979637 | ||
| Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell cancer of the oropharynx | Q74107308 | ||
| Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor | Q74424215 | ||
| Bcl-2 expression correlates with apoptosis induction but not loss of clonogenic survival in small cell lung cancer cell lines treated with etoposide | Q77639789 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 41-54 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Involvement of the hepatocyte growth factor/scatter factor receptor c-met and of Bcl-xL in the resistance of oropharyngeal cancer to ionizing radiation. | |
| P478 | volume | 96 |
| Q92821373 | Adaptive Responses to Monotherapy in Head and Neck Cancer: Interventions for Rationale-Based Therapeutic Combinations |
| Q35567264 | Alterations in the apoptotic machinery and their potential role in anticancer drug resistance |
| Q37349935 | Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma |
| Q39838383 | Candidate Biomarkers for HPV-Negative Head and Neck Cancer Identified via Gene Expression Barcode Analysis |
| Q49414583 | Clinicopathological impacts of high c-Met expression in head and neck squamous cell carcinoma: a meta-analysis and review |
| Q34707942 | Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expression |
| Q28534291 | Control of cellular Bcl-xL levels by deamidation-regulated degradation |
| Q37694026 | Effect of PF-02341066 and radiation on non-small cell lung cancer cells. |
| Q37746309 | Epstein-Barr virus encoded microRNA BART7 regulates radiation sensitivity of nasopharyngeal carcinoma. |
| Q35174872 | HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer |
| Q38883827 | HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment. |
| Q33607965 | Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for Treatment |
| Q55470167 | In vitro and in vivo potentiating the cytotoxic effect of radiation on human U251 gliomas by the c-Met antisense oligodeoxynucleotides. |
| Q34972637 | MET Inhibition Results in DNA Breaks and Synergistically Sensitizes Tumor Cells to DNA-Damaging Agents Potentially by Breaching a Damage-Induced Checkpoint Arrest |
| Q37490555 | MET genetic abnormalities unreliable for patient selection for therapeutic intervention in oropharyngeal squamous cell carcinoma |
| Q38956316 | MET overexpression and gene amplification in NSCLC: a clinical perspective. |
| Q37392930 | Met and its ligand HGF are associated with clinical outcome in breast cancer |
| Q47281319 | Metastatic squamous cell carcinoma cells that overexpress c-Met exhibit enhanced angiogenesis factor expression, scattering and metastasis in response to hepatocyte growth factor |
| Q36828371 | Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapy |
| Q38118439 | Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition |
| Q38602875 | Outcomes in Advanced Head and Neck Cancer Treated with Up-front Neck Dissection prior to (Chemo)Radiotherapy |
| Q51755668 | P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis. |
| Q38869428 | Personalized Radiation Oncology: Epidermal Growth Factor Receptor and Other Receptor Tyrosine Kinase Inhibitors |
| Q38045266 | Prognostic biomarkers of survival in oropharyngeal squamous cell carcinoma: systematic review and meta-analysis. |
| Q55717696 | Prognostic role of c-Met in head and neck squamous cell cancer tissues: a meta-analysis. |
| Q40086138 | Radiation-enhanced hepatocyte growth factor secretion in malignant glioma cell lines |
| Q30971455 | Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family |
| Q64244272 | Reprogramming of Energy Metabolism in Response to Radiotherapy in Head and Neck Squamous Cell Carcinoma |
| Q91306867 | Role of c-Met expression on prognosis of head and neck cancer: A literature review and meta-analysis |
| Q38167258 | Role of met axis in head and neck cancer |
| Q92258309 | Single Nucleotide Polymorphism rs6942067 Is a Risk Factor in Young and in Non-Smoking Patients with HPV Negative Head and Neck Squamous Cell Carcinoma |
| Q26866936 | Targeting the Bcl-2 family for cancer therapy |
| Q37331862 | Targeting the Met signaling pathway in renal cancer. |
| Q30494514 | The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma |
| Q35078950 | The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response-Biological and Clinical Aspects |
| Q48635543 | The clinical value of serum hepatocyte growth factor levels in patients undergoing primary radiotherapy for glioma: effect on progression-free survival |
| Q36720868 | The concurrent chemoradiation paradigm--general principles |
Search more.